- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Investment highlight:
Last December, we downgraded our banking sector rating from Overweight to Equalweight due to three major concerns, namely narrowing net interest margins (NIMs), weakening asset quality, and rising capital pressure. Since then, the sector has corrected by 1%, underperforming the HSCEI by 7ppts. However, we note marginal improvement for all three factors, and thus upgrade our sector rating from Equalweight to Overweight.
Easing NIM pressure. We were concerned about narrowing NIMs due to a weakening loan structure amid China’s economic downturn and monetary easing last December. However, we note preliminary signals of economic stabilisation and a deceleration of monetary loosening since March. This resulted in improving effective loans demand and rising risk appetite from banks, which led to rising loan yields. The proportion of medium- to long-term enterprise loans reached 40% in January- April (vs 36% in 2018, 46% in 2017, and 33% in 2016), while the proportion of medium- to long-term
household loans reached 25% (vs 31% in 2018, 38% in 2017, and 45% in 2016). The sector average NIM increased to 1.64% in 1Q19 (vs 1.58% in 2018 and 1.51% in 2017). We see limited room for further monetary easing, given the policy stance implied by the politburo on 19 April, which stressed the importance of structural deleveraging. As monetary loosening slows, we expect the rising interest rate curve in the interbank market and bond market to improve the pricing power of bank loans and ease the NIM pressure in 2019.
Controllable asset quality risks. We were also concerned about increasing asset quality risks due to rising economic downward pressure and loan exposure to private firms. However, thanks to continuous loan structure adjustments and non-performing loan (NPL) disposal, the sector average NPL ratio decreased to 1.53% in end-1Q19 (vs 1.55% in end-2018 and 1.60% in end-2017), while the coverage ratio rose to 208% in end-1Q19 (vs 202% and 177%, respectively).
您可能关注的文档
- 中资美元债跟踪笔记(二):无风险利率波动,中资美元债如何反应.docx
- 中小市值一季报综述:宏观经济增速放缓,竞争加剧方显真成长本色.docx
- 中外股票估值追 踪及对比:仅有中证500估值回升超上期.docx
- 中美自贸区(上):基本理论与国际经验.docx
- 中美贸易摩擦演绎和相关行业影 响分析.docx
- 中美贸易摩擦升级.docx
- 证 券行业月度业绩点评:业绩起伏不改价值本色,行情回落把握上车良机.docx
- 证 券行业动态分析:上市券商2018年年报及2019年1季报综述.docx
- 证 券行业2018年报及2019年一季报业绩综述:2019年一季度业绩强势反弹.docx
- 整合营销行业:营销,行业新发展,以MarTech为方向,正加速迭代.docx
- 银行行业:银行信贷释放空间研判,信贷供给能力充足,银行资本瓶颈无忧.docx
- 银行行业:贸易问题对金融体系影 响的一些探讨.docx
- 医药外包行业专题研究系列:中国市场红利逻辑下,医药外包公司弹性不一样.docx
- 医药生物行业五月投资策略:业绩公布后回归价值,关注医药政策.docx
- 医药生物行业2018年年报和2019年1季报点评:企业持续分化,重点关注创新.docx
- 医药生物行业2018年报&2019一季报业绩回顾:整体趋势向上,个股分化加剧.docx
- 医药生物行业2018年报&2019一季报业绩回顾:行业整体趋势向上,个股分化加剧.docx
- 医药生物行业:原料药5月投资策略,原料药价格总体走势较弱,肝素出口持续回暖.docx
- 医药生物行业:行业分化,优秀公司脱颖而出.docx
- 医药生物行业:2018年药品监管统计年报发布.docx
文档评论(0)